Cardiac Transplantation in Survivors of Lymphoma

Abstract

Although the numbers are small, these data strongly suggest that there is an increased mortality risk for cardiac transplant recipients with prior HD who have undergone splenectomy.

Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies

“…Patients with previously treated Hodgkin disease have been reported to carry a 5-fold excess risk of a second cancer during 15 years of followup. 11,19 However, within the hematopoietic malignancy group in our study, only 1 recipient developed new malignancy post-Tx, indicating a low recurrence rate of 13%. In contrast, fatal recurrence developed in all recipients with cardiac sarcoma pre-Tx.…”

“…4,5 Only small series with short observation times and without detailed analysis of the importance of the duration of pre-operative cancer-free interval have been published. [6][7][8][9][10][11][12] Hence, our aim was to investigate the influence of pre-Tx malignancy on post-Tx recurrence and long-term survival, focusing on preoperative cancer-free intervals in lung and heart Tx recipients.…”

Heart transplantation and chronic lymphocytic leukemia: a successful case at 2 years of follow-up

“…All of the aforementioned experiences suggest that carefully selected patients with "cured malignancies" could benefit from HT and have a successful outcome. [3][4][5][6][7][8] Our single experience is in accordance with this proposition and we believe that a satisfactory outcome of HT can be expected in CLL patients with a low-to-intermediate risk.…”

Solid Organ Transplantation in Patients With a History of Lymphoma

“…A survey of transplantation centers registered with the United Network for Organ Sharing (UNOS) and the International Society for Heart and Lung Transplantation identified 34 patients with a history of lymphoma before cardiac transplantation. 28 Sixteen patients had a previous diagnosis of Hodgkin lymphoma. The median disease-free interval before transplantation was 15 years.…”